H-1-[C-13] NMR Spectroscopy of the Rat Brain During Infusion of [2-C-13] Acetate at 14.1 T by Xin, Lijing et al.
FULL PAPERS
1H-[13C] NMR Spectroscopy of the Rat Brain During
Infusion of [2-13C] Acetate at 14.1 T
Lijing Xin,1 Vladimı´r Mlyna´rik,1 Bernard Lanz,2 Hanne Frenkel,2 and Rolf Gruetter1–3*
Full signal intensity 1H-[13C] NMR spectroscopy, combining a
preceding 13C-editing block based on an inversion BISEP (B1-
insensitive spectral editing pulse) with a spin-echo coher-
ence–based localization, was developed and implemented at
14.1 T. 13C editing of the proposed scheme was achieved by
turning on and off the 13C adiabatic full passage in the 13C-
editing block to prepare inverted and noninverted 13C-coupled
1H coherences along the longitudinal axis prior to localization.
The novel 1H-[13C] NMR approach was applied in vivo under
infusion of the glia-specific substrate [2-13C] acetate. Besides
a ~50% improvement in sensitivity, spectral dispersion was
enhanced at 14.1 T, especially for J-coupled metabolites such
as glutamate and glutamine. A more distinct spectral struc-
ture at 1.9–2.2 ppm(parts per million) was observed, e.g., glu-
tamate C3 showed a doublet pattern in both simulated 1H
spectrum and in vivo 13C-edited 1H NMR spectra. Besides 13C
time courses of glutamate C4 and glutamine C4, the time
courses of glutamate C3 and glutamine C3 obtained by 1H-
[13C] NMR spectroscopy were reported for the first time. Such
capability should greatly improve the ability to study neuron-
glial metabolism using 1H-observed 13C-edited NMR
spectroscopy. Magn Reson Med 64:334–340, 2010. VC 2010
Wiley-Liss, Inc.
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Dynamic detection of 13C label incorporation by 13C
NMR spectroscopy in conjunction with 13C label admin-
istration allows the investigation of neuroglial metabo-
lism in vivo (see de Graaf et al. (1) and Gruetter et al. (2).
for reviews). By dynamically measuring 13C incorpora-
tion into different carbon positions of NMR-detectable
metabolic products such as glutamate (Glu) and gluta-
mine (Gln) during the infusion of labeled substrate and
then fitting this dynamic information with a suitable
mathematical model, several crucial metabolic fluxes,
e.g., exchange rate between 2-oxoglutarate and Glu, the
tricarboxylic acid (TCA) cycle rate and the Glu-Gln cycle
rate, can be quantitatively derived (3–5). Generally, 13C-
enriched glucose, such as [1-13C] or [1, 6-13C2] glucose,
has been used as the substrate (6,7).
In the last two decades, 13C-labeled acetate (Ace) has
been employed in a few 13C NMR studies (8–17). Since
Ace is taken up exclusively by astrocytes (18), the glial
Gln pool will be labeled prior to the larger neuronal Glu
pool (19). Hence, 13C-labeled Ace infusion could poten-
tially increase the accuracy of the assessment of the Glu-
Gln cycle rate and the TCA cycle rate in astrocytes (20).
However, due to the smaller pool size of Gln (3 mmol/
g) (21) and strong labeling dilution effect of the neuronal
Glu, 13C-labeled signals are much smaller when using
Ace infusion compared to those acquired with glucose
infusion, which increases demands on the measurement
sensitivity. To date, the dynamic 13C labeling time
courses reported by in vivo studies using 13C-labeled
Ace were limited to the measurement of the C4 position
of Glu and Gln (11,22).
The measurement of 13C labeling has been achieved
using either direct or indirect 13C NMR detection
(3,6,23–25). Direct detection of 13C NMR signals allows
the individual measurement of turnover of C2, C3, and
C4 positions of Glu and Gln due to the large chemical-
shift dispersion of the 13C spectral lines. However, the
inherently low sensitivity of 13C limits the spatial resolu-
tion to 400 mL (26). To increase the sensitivity, indirect
detection of 13C through the more sensitive 1H nuclei is
an alternative, albeit at the expense of a lower spectral
resolution, such as the partial separation of labeling in
Glu and Gln (23,25), which limits the achievable
dynamic information and the reliability of the two-com-
partment metabolic modeling (20). For instance, Pfeuffer
et al. (23) proposed a modified stimulated echo acquisi-
tion mode localization for performing adiabatic carbon
editing and decoupling, and demonstrated the measure-
ment of GluC4 and GlnC4 time courses with glucose
infusion at 9.4 T. A proton-observed carbon-edited NMR
sequence (7) based on three-dimensional image-selected
in vivo spectroscopy localization was performed with
glucose infusion at 7 T in rat brain, and the reported
time courses were limited to GluC4, GlnC4, and GluC3 þ
GlnC3 (27).
By further increasing the magnetic field strength, the
signal-to-noise ratio and spectral resolution of 1H-[13C]
NMR spectroscopy are improved, especially for J-
coupled metabolites (28), which will potentially lead to
the measurement of additional labeling information, e.g.,
GluC3 and GlnC3 time courses.
In the present study, a full signal intensity 1H-[13C]
NMR spectroscopy, combining the spin-echo coherence-
based localization ‘‘SPECIAL’’ (SPin ECho, full Intensity
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Acquired Localized spectroscopy) (29) with a preceding
13C-editing block based on an inversion BISEP (B1-insen-
sitive spectral editing pulse) (30), was implemented at
an ultrahigh magnetic field strength of 14.1 T and vali-
dated in vitro and in vivo during infusion of [2-13C] Ace.
We further demonstrated improved 1H-[13C] NMR spec-
tral resolution at 14.1 T and feasibility of measuring




All animal preparation procedures were performed
according to local and federal guidelines and were
approved by the local ethics committee. Six healthy
Sprague-Dawley rats (263 6 19 g, mean 6 standard devi-
ation) were fasted overnight (15–16 h), with free access
to water before the studies. Animals were intubated and
ventilated by 2% isoflurane during the surgery. Both
femoral veins were catheterized for continuous infusion
of a-chloralose (Fisher Scientific, Pittsburgh, PA) and
99% enriched [2-13C] sodium Ace (Sigma-Aldrich, St.
Louis, MO). One femoral artery was cannulated for blood
sampling. After preparation, anesthesia was achieved by
an 80 mg/kg initial bolus of a-chloralose, followed by
continuous infusion at a rate of 26.7 mg/kg/h. The ani-
mal was placed in a homemade holder and the head was
stereotaxically fixed. Respiration rate and blood pressure
were continuously monitored (SA Instruments Inc., NY).
Body temperature was measured by a rectal thermosen-
sor and maintained at 38.0 6 0.5C by circulating heated
water. A variable bolus of 3-M 99% enriched [2-13C] so-
dium Ace (pH ¼ 6) was given over two consecutive
5-min periods, with rates of 1.8 mmol/min/kg and
1.1 mmol/min/kg, respectively, and then a continuous
rate of 0.3 mmol/min/kg was applied. The infused vol-
ume of Ace solution was 5 mL in total. Arterial blood
(200 mL) was sampled approximately every 30 min for
monitoring blood gases (pCO2 ¼ 39 6 2 mm Hg, pO2 >
100 mm Hg), pH (7.41 6 0.03), and the analysis of
plasma Ace concentration and isotopic enrichment. An
aliquot of arterial blood was immediately centrifuged
and stored in a nearby 80C freezer for subsequent
processing. The total amount of blood draw was below
10% of the total blood volume of the rat.
Analysis of Blood Plasma and High-Resolution
NMR Spectroscopy
Plasma samples were thawed and immediately centri-
fuged (12,000g) with a centrifugal filter with a molecular-
weight cutoff of 10 kDa (Vivaspin 500; Sartorius AG,
Goettingen, Germany). The ultrafiltrate of the plasma was
lyophilized and dissolved in 400 mL D2O containing
0.774 mM 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid so-
dium salt (sodium salt; Ciba Geigy AG, Basel, Switzer-
land), which was used as a chemical shift and internal
concentration reference for high-resolution NMR spectros-
copy. The measurements were performed on a 500-MHz
vertical-bore spectrometer (Bruker, Fallanden, Switzer-
land). One-dimensional 1H pulse-and-acquire was used to
measure the isotopic enrichment and the concentration of
Ace in the blood plasma (pulse repetition time ¼ 15 sec).
1H-[13C] NMR Sequence
The proposed 1H-[13C] NMR sequence termed SPECIAL-
BISEP was the combination of the SPECIAL localization
sequence and a preceding 13C-editing block based on the
inversion BISEP (Fig. 1a).
FIG. 1. a: The sequence diagram of SPECIAL-BISEP (TE ¼ 2.8 ms). The editing was achieved by applying an AFP in the 13C channel
on alternate scans. b: In vitro validation of the editing scheme was performed at 14.1 T on a solution of 67% enriched [2-13C] sodium
Ace (no 13C decoupling during the acquisition was applied). When the 13C AFP is turned off, the inversion BISEP pulse acts as a 0
BIR-4 pulse (top), while when AFP is turned on, 13C-coupled 1H resonances are inverted (middle). In the difference spectrum (bottom),
the uncoupled resonances (1H-[2-12C]) are minimized and only the 13C-coupled 1H resonances (1H-[2-13C]) are detected.
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The inversion BISEP, which was based on a segmented
0 BIR-4 (B1-insensitive rotation with 4 segments) pulse
with two pulse interval delays (t ¼ 1/2J), consisted of
three segments in the 1H channel (time-reversed adia-
batic half-passage [p/2, 0.5 ms], adiabatic full passage
[AFP; p, 1 ms], and adiabatic half-passage [p/2, 0.5 ms])
and one AFP (1 ms) in the 13C channel centered at the
central segment of 0 BIR-4 pulse in the 1H channel (30).
The modulation functions of the AFP and adiabatic half-
passage were based on hyperbolic tangent and tangent
functions. Using product operator formalism to describe
coherence evolution of 13C (S)-coupled 1H (I) spins at the
end of the BISEP, the coherence is Iz cos(2pJt)  2IxSz
sin(2pJt). When using the time delay t ¼ 1/2J (J ¼ 127
Hz), Iz is obtained to achieve the inversion of 13C-
coupled 1H coherences. On the other hand, without the
AFP in the 13C channel the 13C-editing block acts as a 0
BIR-4 pulse and the coherence returns to þIz. Therefore,
by turning off (unedited) and on (edited) the AFP in the
13C channel, 6Iz are prepared prior to the localization.
Since the uncoupled signals (corresponding to protons
bound to 12C) undergo only segmented 0 BIR-4 pulse
and return to the z axis in both unedited and edited
acquisitions, the subtracted spectrum contained 1H
resonances bound to 13C.
The bandwidth of the inversion BISEP was 2 kHz
(3.3 ppm at 14.1 T) in 1H channel, where gB1max/2p ¼
6.7 kHz, and 12 kHz (80 ppm at 14.1 T) at the 13C fre-
quency, where gB2max/2p  7 kHz. The frequency offsets
were set to the resonance frequencies of GluC4 protons
and carbon (2.34 ppm and 35 ppm), respectively.
Following the 13C-editing block, the SPECIAL localiza-
tion sequence based on the combination of one-dimen-
sional image-selected in vivo spectroscopy and slice-selec-
tive spin-echo (29) was used to detect the prepared 6Iz
from a selected volume of interest. An ultrashort echo time
(TE) of 2.8 ms was used to attain full signal intensity and
minimize spectral evolution due to 1H-1H coupling. Outer
volume suppression was achieved by six adiabatic hyper-
bolic secant pulses in three outer-volume-suppression mod-
ules interleaved with VAPOR (VAriable Pulse power and
Optimized Relaxation delays) water suppression (31). An
additional water-suppression pulse was implemented
between one-dimensional image-selected in vivo spectros-
copy and the spin-echo module. Adiabatic 13C decoupling
was based on an adiabatic hyperbolic secant (HS8) pulse
applied with both MLEV-4 and a five-step phase cycling
(23) during the 145-ms acquisition time.
In Vivo MRS and Quantification
All experiments were carried out on an animal MRI sys-
tem (Varian, Palo Alto, CA) interfaced to a 14.1-T, 26-cm,
horizontal-bore magnet (Magnex Scientific, Oxford, UK)
with actively shielded gradients (12-cm inner diameter,
400 mT/m in 120 ms). A homemade 13 mm-diameter geo-
metrically decoupled quadrature 1H surface coil with a 10
mm-diameter single-loop linear 13C coil was used as both
transmitter and receiver. At the center of the 13C coil, a
sphere filled with 99% 13C-enriched formic acid was
placed to provide a reference signal for power calibration
of the adiabatic pulses in the 13C channel.
Fast spin-echo images (effective TE ¼ 45 ms, echo
train length ¼ 8, pulse repetition time ¼ 2.5 sec, number
of transitions ¼ 2, slice thickness ¼ 1 mm, field of view
¼ 30  30 mm2, matrix ¼ 256  256) were acquired for
positioning of the volume of interest. Localized 1H-[13C]
spectra were acquired from a volume of 144 mL (8  3 
6 mm3) centered in cerebral cortex of the rat brain. To
optimize the magnetic field homogeneity in the volume
of interest, an echo-planar imaging version of FASTMAP
(32) was used to adjust all first- and second-order shims,
which achieved a full width at half maximum of the
water signal of 20–22 Hz in vivo.
During 150 min of 99% enriched [2-13C] sodium Ace
infusion, localized proton signal (64 averages, pulse rep-
etition time ¼ 4 sec) was continuously acquired with
and without applying the 13C AFP in an interleaved
fashion. In vivo spectra were analyzed by LCModel (33).
Two basis sets were employed: (i) a standard basis set
for unedited 1H spectra contained a measured macromo-
lecular baseline and simulated metabolite spectra (34);
(ii) a basis set for 13C-edited 1H NMR spectra contained
simulated metabolite spectra of Ace C2, N-acetyl aspar-
tate C6, Glu (C2, C3, and C4), Gln (C2, C3, and C4), g-
aminobutyric acid (C2, C3, and C4), aspartate (C2 and
C3), and total creatine (C2 and C3). AceC2 (1.9 ppm)
served as a reference for frequency and phase adjustment
of the 13C-edited 1H spectra. After LCModel analysis, iso-
topic enrichment of metabolites such as GluC4, GlnC4,
GluC3, GlnC3, and AceC2 was calculated directly from
the relative concentration ratio of 13C concentration
obtained from 13C-edited 1H NMR spectra and the total
concentration (12C þ 13C) obtained from unedited 1H
spectra. Total creatine was assumed to be 8 mmol/g for
calculating the absolute concentration (21,22).
Spectral Simulation of Glu and Gln
Proton spectra of Glu and Gln under spin-echo excitation
at TE ¼ 2.8 ms were simulated at three different mag-
netic field strengths of 7, 9.4, and 14.1 T. Quantum
mechanics simulations, based on density matrix formal-
ism, were performed in Matlab (version 7.5; The Math-
Works, Inc., Natick, MA) (35). Published chemical shifts,
i.e., 3.74 ppm (2CH), 2.04 ppm and 2.12 ppm (3CH2), and
2.34 ppm and 2.35 ppm (4CH2) for Glu and 3.75 ppm
(2CH), 2.13 ppm and 2.11 ppm (3CH2), and 2.43 ppm and
2.45 ppm (4CH2) for Gln, and J-coupling constants (36)
were used in the calculation. The line widths of metabo-
lites were set to 8, 10, and 18 Hz for 7, 9.4, and 14.1 T,
respectively.
RESULTS
Isotopic enrichment of AceC2 in the blood reached over
95% within 5 min after starting the infusion of 99%
enriched [2-13C] sodium Ace and was stable at around
90% during the whole experiment. The concentration of
plasma Ace during the experiment was 9 6 3 mM.
To validate the performance of the SPECIAL-BISEP
scheme, a 20-mL plastic cylinder containing 200-mM
[2-13C] sodium Ace and 100-mM unlabeled sodium Ace
was prepared. Applying the 13C AFP at the 13C
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resonance of AceC2, the 13C-coupled 1H resonances were
inverted (Fig. 1b, middle). When the 13C AFP was turned
off, 13C-coupled 1H resonances were detected in phase
with the central 1H-[12C] resonances (Fig. 1b, top).
Subtracting the noninverted spectrum (Fig. 1b, top) from
the inverted spectrum (Fig. 1b, middle), uncoupled
resonances were successfully eliminated and 13C-
coupled 1H resonances were exclusively retained (Fig.
1b, bottom).
To demonstrate the improvement of spectral resolution
for J-coupled metabolites at 14.1 T, 1H spectra of Glu and
Gln at different magnetic field strengths, i.e., 7, 9.4, and
14.1 T, were simulated (Fig. 2). Since the line width of the
multiplets of Glu and Gln is mainly determined by the J-
coupling constant, which is independent of the amplitude
of static field, the spectral resolution was expected to be
substantially improved, despite the increase in the singlet
line width with the amplitude of static field. Note that at
14.1 T, the C3 of Glu was a more distinct doublet of its
nonequivalent 1H resonances at 2.04 ppm and 2.12 ppm
compared to that at both 7 and 9.4 T.
To demonstrate the 1H-[13C] NMR editing scheme in
vivo, NMR experiments in conjunction with [2-13C] Ace
infusion were performed. The in vivo unedited 1H spec-
trum of rat brain acquired by SPECIAL-BISEP during
infusion of [2-13C] Ace demonstrated new spectral fea-
tures at 14.1 T, such as better-separated spectral lines at
1.9–2.2 ppm, which correspond to Glu, Gln, N-acetyl
aspartate, and Ace resonances (Fig. 3).
The 45-min averaged 13C-edited 1H NMR spectrum
acquired 106 min after starting Ace infusion exhibited
spectral features ascribed to multiplets of GluC3, GlnC3,
and N-acetyl aspartate C6 (Fig. 3). In addition, the major
resonance signal, i.e., GluC4 at 2.34 ppm, was clearly
separated from the GlnC4 resonance at 2.44 ppm.
LCModel analysis performed using a basis set com-
posed of the individual position of molecules resulted in
FIG. 2. Simulated 1H spectra of Glu and Gln under spin-echo ex-
citation at 7, 9.4, and 14.1 T, with line widths of 8, 10, and 18 Hz,
respectively (TE ¼ 2.8 ms). The concentration of Glu and Gln
used in the simulation was 8.3 mmol/g and 2.7 mmol/g, respec-
tively (21).
FIG. 3. Averaged unedited and edited 1H-[13C] NMR spectrum
acquired in vivo at 14.1 T for 45 min after 106 min of Ace infu-
sion. Gaussian weighting function (exp [t2/0.082]) was applied
before Fourier transformation. No baseline correction and water
signal removal were applied. The fit of the 13C-edited 1H NMR
spectrum, fit residual, and individual fit of Glu (C2, C3, and C4),
Gln (C2, C3, and C4), AceC2 and N-acetyl aspartate (NAA) C6 are
shown. A detailed region of in vivo 1H-[13C] NMR spectrum (thick
line) and spectral fits (thin lines) is shown in the inset.
1H-[13C] NMR Spectroscopy at 14.1 T 337
an excellent fit of the 13C-edited 1H spectrum with mini-
mal fit residual (Fig. 3). Note that GluC3 exhibited a dis-
tinct doublet structure expected from the two nonequiva-
lent protons, as shown in the simulated spectrum
(Fig. 2).
1H-[13C] NMR spectra summed every 9 min (128
scans) demonstrated the dynamic 13C incorporation (Fig.
4). From the stack plot, it is clear that after 13C incorpo-
ration into AceC2, GlnC4 and GluC4 were labeled first,
followed by labeling in the C3 and C2 position of Glu
and Gln.
From the analysis of the unedited 1H spectra and 13C-
edited 1H spectra (64 averages), total concentration of
metabolites (12C þ 13C) and the concentration of 13C-la-
beled metabolites were obtained. Cramer-Rao lower
bounds (expressed in concentration unit) of the concen-
tration of GluC4, GlnC4, GluC3, and GlnC3 were 0.047 6
0.004 mmol/g, 0.048 6 0.004 mmol/g, 0.13 6 0.02 mmol/
g, and 0.081 6 0.009 mmol/g (mean 6 standard devia-
tion; n ¼ 6), respectively, in 4.5-min spectra. Dynamic
isotopic enrichment of GluC4, C3 and GlnC4, C3 was cal-
culated by dividing the concentration of 13C-labeled
metabolites by the total concentration of the respective
metabolites. All data points were used in the 13C-label
time courses. Average time courses of GluC4, C3 and
GlnC4, C3 (n ¼ 6) with a time resolution of 4.5 min
(each data point contains 64 scans) are shown in Fig. 5.
At steady state, the isotopic enrichment of GluC4 and
GlnC4 was 16% and 35%, respectively. The labeling of
GluC3 and GlnC3 continued to increase during the
whole experiment, and their isotopic enrichment
reached 12% and 20% at 150 min, respectively. A
small increase in the isotopic enrichment of N-acetyl
aspartate C6 was also observed (not shown) but remained
below 4% during the infusion experiment, which can
be ascribed to its slow metabolism (37).
DISCUSSION
The present study introduced a novel 1H-[13C] NMR
spectroscopic technique that attained full signal intensity
by using a BISEP-based 13C-editing block combined with
the SPECIAL localization at ultrashort TE.
The 180 BISEP, originally introduced as a refocusing
pulse (30), was used in the proposed scheme as a 13C
inversion pulse for inverting 13C-coupled 1H coherences
on alternate scans prior to localization (Fig. 1a). As a
13C-editing adiabatic pulse, BISEP enabled us to mini-
mize the signal loss due to the inhomogeneous
FIG. 4. Stack plot of time-resolved 13C-edited 1H spectra from
the rat brain in vivo during [2-13C] Ace infusion. Each spectrum
was summed over 9 min (number of transitions ¼ 128) scans
and gaussian weighting functions (exp [t2/0.082]) were applied.
No baseline correction and water signal removal were applied.
Data are from the same animal shown in Fig. 3.
FIG. 5. Average time courses of GlnC4 ((a), closed square), GluC4
((a), open diamond), GlnC3 ((b), closed square), and GluC3 ((b),
open diamond), with 4.5-min time resolution during 150-min
[2-13C] Ace infusion (n ¼ 6).
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amplitude of radiofrequency field typically present at
high magnetic field strength. In contrast to a proton-
observed carbon-edited sequence (7), the BISEP 13C edit-
ing block generates inverted and noninverted magnetiza-
tion along the z axis prior to the localization. Therefore,
13C editing is independent of the subsequent localization
part, which allows one to combine the BISEP with any
localization sequence or spectral editing sequence used
for the detection of specific metabolites.
Four scans in total were necessary for accomplishing
13C-localized editing in the proposed scheme. Compared
to the proton-observed carbon-edited type of 1H-[13C]
NMR sequence combined with three-dimensional image-
selected in vivo spectroscopy localization (25), which
requires the addition and subtraction of 16 scans, the
proposed approach is based on four times fewer add-sub-
tract steps. In addition, outer volume suppression in all
three localization dimensions further minimizes the
potential contamination from the tissue outside the VOI
(volume of interest) caused by add-subtract scheme. This
is expected to lead to a more robust detection of 13C
label.
In the unedited 1H-[13C] NMR spectra, LCModel was
used to analyze the spectrum (33). Moreover, instead of
using a TE of 7.9 ms (1/JCH) as in the proton-observed
carbon-edited type of editing sequence, an ultrashort TE
of 2.8 ms was used, which minimized the spectral modu-
lation and signal reduction due to 1H-1H J coupling. This
had the advantage that a standard, preexisting basis set
including a measured macromolecule baseline was
directly used for quantifying the unedited 1H spectra in
LCModel analysis.
When using [2-13C] Ace as a substrate, the smaller glial
Gln pool is labeled prior to the larger neuronal Glu pool.
Substantial dilution of Glu by unlabeled carbon from the
more active neuronal TCA cycle leads to a lower isotopic
enrichment of metabolites compared to using [1-13C] or
[1,6-13C2] glucose as a substrate. Therefore, it was impor-
tant to optimize the sensitivity of the measurement,
which was accomplished in this study by using full-sen-
sitivity 1H-[13C] NMR spectroscopy and by taking advant-
age of 50% increase in sensitivity at 14.1 T compared
to 9.4 T (34).
Since the field inhomogeneity increases with magnetic
field strength, implementation of an efficient automatic
shimming scheme such as FASTMAP was crucial to es-
tablish high spectral quality. In this study, the typical
line width of singlets (total creatine at 3.03 ppm) after
the first- and second-order shimming adjustment was 17-
18 Hz for a VOI of 144 mL. Although the line width of
singlets was increased at 14.1 T compared to 9.4 T, the
line width of J-coupled metabolites such as Glu and Gln
is determined by the J-coupling constant and thus hardly
affected by the increased amplitude of static field (Fig.
2). Hence, the improvement in the chemical shift disper-
sion was prominent for J-coupled resonances at 14.1 T,
e.g., GluC3, which clearly showed a better-resolved dou-
blet structure in the simulated 1H spectrum and in vivo
13C-edited 1H NMR spectra (Fig. 2 and Fig. 3) compared
to the lower magnetic field strength (23), as well as a
clear separation of GlnC4 and GluC4. Therefore, this
study allowed for the first time a separate measurement
of time courses of GluC3 and GlnC3 by 1H-[13C] NMR
spectroscopy (Fig. 5). These two extra time courses are
likely to improve the reliability of metabolic modeling
for assessing metabolic fluxes (20).
The accuracy of quantification of the spectra was
mainly determined by the quality of the spectra in terms
of signal-to-noise ratio and spectral dispersion, which
are reflected in Cramer-Rao lower bounds of the metabo-
lite concentrations calculated by LCModel. At 14.1 T,
the improved signal-to-noise ratio and separation in Glu
and Gln resonances led to 50% lower Cramer-Rao
lower bounds for GluC4, C3 and GlnC4, C3 compared to
those at 9.4 T (38).
Although LCModel analysis was used in this study,
the improved spectral resolution at 14.1 T, such as
resolved GluC4 and GlnC4 resonances, as well as the dis-
tinct spectral pattern of GluC3 and GlnC3, should also
permit the use of other quantification methods, e.g.,
jMRUI (magnetic resonance user interface) (39) or con-
strained peak fitting.
The 13C-labeled metabolites (Fig. 3) detected during
[2-13C] Ace infusion observed in this study were similar
to those observed under glucose infusion (23). Neverthe-
less, the turnover pattern of Glu and Gln obtained with
[2-13C] Ace infusion was significantly different with that
acquired with infusing 13C-enriched glucose. Glutamine
labeling showed a faster increase in both C3 and C4 posi-
tion relative to Glu-labeling time courses. Isotopic
enrichment of GlnC4 at steady state was 2.2 times
higher than that of GluC4 (Fig. 4). The isotopic enrich-
ments obtained in the present study were similar to
those reported by Deelchand et al. (22), i.e., GluC4 (14%)
and GlnC4 (44%).
The high sensitivity achieved from a VOI of 144 mL
with a temporal resolution of 4.5 min under Ace infu-
sion at 14.1 T indicates that at such a magnetic field
strength, the proposed sequence could be used to study
the 13C turnover in a smaller, more specific brain region.
Moreover, with [1-13C]-, [U-13C6]-, or [1,6-
13C2]-labeled
glucose as a substrate, studies of separate GluC3 and
GlnC3 time courses and even time courses of other low-
concentration metabolites should be feasible using the
described 1H-[13C] NMR technique at 14.1 T.
Ace has been infused in humans but with a lower
infusion rate (e.g., 3 mg/kg/min) (11,14); hence, the pro-
posed approach should be of advantage for human stud-
ies. The SPECIAL localization sequence and BIR-4 pulses
as a part of the FAST(EST)MAP are currently used on
our clinical 3- and 7-T scanners (40). It should be
straightforward to include a 13C p pulse into BISEP. Pro-
vided that sufficient radiofrequency power can be deliv-
ered for 13C decoupling within SAR guidelines, the pro-
posed approach can be extended to human studies.
CONCLUSION
We conclude that the 1H-[13C] NMR sequence SPECIAL-
BISEP provides a versatile scheme of measuring 13C
labeling through protons, with full signal sensitivity.
Separate measurements of time-resolved GluC4, GlnC4,
GlnC3, and GluC3 are possible at 14.1 T, which likely
improves the ability to study neuron-glial metabolism.
1H-[13C] NMR Spectroscopy at 14.1 T 339
ACKNOWLEDGMENTS
The authors thank Dr. Giulio Gambarota for helping with
the preparation of the manuscript and Dr. Paul Vasos for
helping with the measurement at the high-resolution spec-
trometer. The work was supported by Centre d’Imagerie
BioMe´dicale of the University of Lausanne (UNIL), Uni-
versity of Geneva (UNIGE), Hoˆpitaux Universitaires de
Gene`ve (HUG), Centre Hospitalier Universitaire Vaudois
(CHUV) and Ecole Polytechnique Federale de Lausanne
(EPFL), the Leenaards, Jeantet Foundations and Swiss
National Science Foundation (SNSF 3100A0-116220).
REFERENCES
1. de Graaf RA, Mason GF, Patel AB, Behar KL, Rothman DL. In vivo
1H-[13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed
2003;16:339–357.
2. Gruetter R, Adriany G, Choi IY, Henry PG, Lei H, Oz G. Localized in
vivo 13C NMR spectroscopy of the brain. NMR Biomed 2003;16:
313–338.
3. Sibson NR, Dhankhar A, Mason GF, Behar KL, Rothman DL, Shul-
man RG. In vivo 13C NMR measurements of cerebral glutamine syn-
thesis as evidence for glutamate-glutamine cycling. Proc Natl Acad
Sci U|S|A 1997;94:2699–2704.
4. Henry PG, Adriany G, Deelchand D, Gruetter R, Marjanska M, Oz G,
Seaquist ER, Shestov A, Ugurbil K. In vivo 13C NMR spectroscopy
and metabolic modeling in the brain: a practical perspective. Magn
Reson Imaging 2006;24:527–539.
5. Gruetter R, Seaquist ER, Ugurbil K. A mathematical model of com-
partmentalized neurotransmitter metabolism in the human brain. Am
J Physiol Endocrinol Metab 2001;281:E100–112.
6. Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shul-
man GI, Prichard JW, Shulman RG. Localized 13C NMR spectroscopy
in the human brain of amino acid labeling from D-[1-13C]glucose.
J Neurochem 1994;63:1377–1385.
7. Rothman DL, Behar KL, Hetherington HP, den Hollander JA, Bendall
MR, Petroff OA, Shulman RG. 1H-observe/13C-decouple spectroscopic
measurements of lactate and glutamate in the rat brain in vivo. Proc
Natl Acad Sci U|S|A 1985;82:1633–1637.
8. Badar-Goffer RS, Bachelard HS, Morris PG. Cerebral metabolism of
acetate and glucose studied by 13C-N.M.R. spectroscopy: a technique
for investigating metabolic compartmentation in the brain. Biochem J
1990;266:133–139.
9. Cerdan S, Kunnecke B, Seelig J. Cerebral metabolism of [1,2-13C2]ace-
tate as detected by in vivo and in vitro 13C NMR. J Biol Chem 1990;
265:12916–12926.
10. Taylor A, McLean M, Morris P, Bachelard H. Approaches to studies
on neuronal/glial relationships by 13C-MRS analysis. Dev Neurosci
1996;18:434–442.
11. Lebon V, Petersen KF, Cline GW, Shen J, Mason GF, Dufour S, Behar
KL, Shulman GI, Rothman DL. Astroglial contribution to brain
energy metabolism in humans revealed by 13C nuclear magnetic reso-
nance spectroscopy: elucidation of the dominant pathway for neuro-
transmitter glutamate repletion and measurement of astrocytic
oxidative metabolism. J Neurosci 2002;22:1523–1531.
12. Bluml S, Moreno-Torres A, Shic F, Nguy CH, Ross BD. Tricarboxylic
acid cycle of glia in the in vivo human brain. NMR Biomed 2002;15:
1–5.
13. Chassain C, Bielicki G, Donnat JP, Renou JP, Eschalier A, Durif F.
Cerebral glutamate metabolism in Parkinson’s disease: an in vivo
dynamic (13)C NMS study in the rat. Exp Neurol 2005;191:276–284.
14. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI.
Increased brain monocarboxylic acid transport and utilization in
type 1 diabetes. Diabetes 2006;55:929–934.
15. Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar
KL. The contribution of GABA to glutamate/glutamine cycling and
energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci
U|S|A 2005;102:5588–5593.
16. Yang J, Li SS, Bacher J, Shen J. Quantification of cortical GABA-glu-
tamine cycling rate using in vivo magnetic resonance signal of
[2-13C]GABA derived from glia-specific substrate [2-13C]acetate. Neu-
rochem Int 2007;50:371–378.
17. Deelchand DK, Nelson C, Shestov AA, Ugurbil K, Henry PG. Simul-
taneous measurement of neuronal and glial metabolism in rat brain
in vivo using co-infusion of [1,6-13C2]glucose and [1,2-13C2]acetate.
J Magn Reson 2009;196:157–163.
18. Waniewski RA, Martin DL. Preferential utilization of acetate by astro-
cytes is attributable to transport. J Neurosci 1998;18:5225–5233.
19. Ottersen OP, Zhang N, Walberg F. Metabolic compartmentation of
glutamate and glutamine: morphological evidence obtained by quan-
titative immunocytochemistry in rat cerebellum. Neuroscience 1992;
46:519–534.
20. Shestov AA, Valette J, Ugurbil K, Henry PG. On the reliability of
(13)C metabolic modeling with two-compartment neuronal-glial mod-
els. J Neurosci Res 2007;85:3294–3303.
21. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neu-
rochemical profile: quantification of 18 metabolites in short-echo-time
(1)H NMR spectra of the rat brain. J Magn Reson 1999;141:104–120.
22. Deelchand DK, Shestov AA, Koski DM, Ugurbil K, Henry PG. Acetate
transport and utilization in the rat brain. J Neurochem 2009;
109(suppl 1):46–54.
23. Pfeuffer J, Tkac I, Choi IY, Merkle H, Ugurbil K, Garwood M, Gruet-
ter R. Localized in vivo 1H NMR detection of neurotransmitter label-
ing in rat brain during infusion of [1-13C] D-glucose. Magn Reson
Med 1999;41:1077–1083.
24. Mason GF, Pan JW, Chu WJ, Newcomer BR, Zhang Y, Orr R, Hether-
ington HP. Measurement of the tricarboxylic acid cycle rate in
human grey and white matter in vivo by 1H-[13C] magnetic resonance
spectroscopy at 4.1T. J Cereb Blood Flow Metab 1999;19:1179–1188.
25. de Graaf RA, Brown PB, Mason GF, Rothman DL, Behar KL. Detec-
tion of [1,6-13C2]-glucose metabolism in rat brain by in vivo 1H-[13C]-
NMR spectroscopy. Magn Reson Med 2003;49:37–46.
26. Henry PG, Tkac I, Gruetter R. 1H-localized broadband 13C NMR spec-
troscopy of the rat brain in vivo at 9.4 T. Magn Reson Med 2003;50:
684–692.
27. de Graaf RA, Mason GF, Patel AB, Rothman DL, Behar KL. Regional
glucose metabolism and glutamatergic neurotransmission in rat brain
in vivo. Proc Natl Acad Sci U|S|A 2004;101:12700–12705.
28. Tkac I, Andersen P, Adriany G, Merkle H, Ugurbil K, Gruetter R. In
vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson
Med 2001;46:451–456.
29. Mlynarik V, Gambarota G, Frenkel H, Gruetter R. Localized short-
echo-time proton MR spectroscopy with full signal-intensity acquisi-
tion. Magn Reson Med 2006;56:965–970.
30. Garwood M, Merkle H. Heteronuclear spectral editing with adiabatic
pulses. J Magn Reson 1991;94:180–185.
31. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy
of rat brain at 1 ms echo time. Magn Reson Med 1999;41:649–656.
32. Gruetter R, Tkac I. Field mapping without reference scan using
asymmetric echo-planar techniques. Magn Reson Med 2000;43:
319–323.
33. Provencher SW. Estimation of metabolite concentrations from local-
ized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679.
34. Mlynarik V, Cudalbu C, Xin L, Gruetter R. 1H NMR spectroscopy of
rat brain in vivo at 14.1 tesla: improvements in quantification of the
neurochemical profile. J Magn Reson 2008;194:163–168.
35. Gambarota G, van der Graaf M, Klomp D, Mulkern RV, Heerschap A.
Echo-time independent signal modulations using PRESS sequences:
a new approach to spectral editing of strongly coupled AB spin sys-
tems. J Magn Reson 2005;177:299–306.
36. Govindaraju V, Young K,Maudsley AA. Proton NMR chemical shifts and
coupling constants for brain metabolites. NMR Biomed 2000;13:129–153.
37. Xin L, Frenkel H, Mlynarik V, Morgenthaler FD, Gruetter R. Selective
resonance suppression 1H-[13C] NMR spectroscopy with asymmetric
adiabatic RF pulses. Magn Reson Med 2009;61:260–266.
38. Xin L, Mlyna´rik V, Frenkel H, Gruetter R. Comparison of glutamate
and glutamine quantitation in rat brain by 1H–[13C] NMR spectros-
copy at 9.4 T and 14.1 T. In: Proceedings of the 26th Annual Meeting
of ESMRMB, Antalya, Turkey, 2009. p 324.
39. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D.
Java-based graphical user interface for MRUI, a software package for
quantitation of in vivo/medical magnetic resonance spectroscopy sig-
nals. Comput Biol Med 2001;31:269–286.
40. Mekle R, Mlynarik V, Gambarota G, Hergt M, Krueger G, Gruetter R.
MR spectroscopy of the human brain with enhanced signal intensity
at ultrashort echo times on a clinical platform at 3T and 7T. Magn
Reson Med 2009;61:1279–1285.
340 Xin et al.
